MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH Has $1.42 Million Holdings in Humana Inc. $HUM

Key Points

• MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH significantly increased its holdings in Humana Inc. by 1,228.1%, totaling $1.42 million by the end of the second quarter.
• Several large investors, including Vanguard Group and AQR Capital Management, have also boosted their stakes in Humana, indicating strong interest from institutional investors.
• Humana announced a quarterly dividend of $0.885 per share, with a payment date set for October 31st, contributing to a 1.4% dividend yield.

MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH increased its holdings in Humana Inc. (NYSE:HUM - Free Report) by 1,228.1% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 5,817 shares of the insurance provider's stock after purchasing an additional 5,379 shares during the quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH's holdings in Humana were worth $1,422,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of HUM. Vanguard Group Inc. increased its stake in shares of Humana by 8.9% in the first quarter. Vanguard Group Inc. now owns 13,972,872 shares of the insurance provider's stock valued at $3,697,222,000 after buying an additional 1,143,662 shares during the period. AQR Capital Management LLC boosted its holdings in Humana by 3,257.5% in the first quarter. AQR Capital Management LLC now owns 1,162,600 shares of the insurance provider's stock valued at $307,624,000 after acquiring an additional 1,127,973 shares during the last quarter. GAMMA Investing LLC increased its position in Humana by 40,881.1% during the 1st quarter. GAMMA Investing LLC now owns 781,099 shares of the insurance provider's stock valued at $2,066,790,000 after purchasing an additional 779,193 shares during the period. Nuveen LLC acquired a new stake in Humana during the 1st quarter valued at approximately $171,220,000. Finally, Dodge & Cox raised its holdings in Humana by 5.5% during the 1st quarter. Dodge & Cox now owns 10,755,215 shares of the insurance provider's stock worth $2,845,830,000 after purchasing an additional 557,175 shares during the last quarter. 92.38% of the stock is owned by institutional investors.

Analyst Ratings Changes

HUM has been the topic of a number of analyst reports. Wall Street Zen lowered shares of Humana from a "buy" rating to a "hold" rating in a research note on Saturday, August 2nd. Morgan Stanley cut their price target on shares of Humana from $290.00 to $277.00 and set an "equal weight" rating on the stock in a research report on Thursday, July 31st. Bank of America lifted their price objective on Humana from $285.00 to $312.00 and gave the stock a "neutral" rating in a research report on Tuesday, September 2nd. Wells Fargo & Company dropped their price objective on Humana from $348.00 to $344.00 and set an "overweight" rating on the stock in a research note on Thursday, August 14th. Finally, Barclays raised their target price on Humana from $275.00 to $315.00 and gave the stock an "equal weight" rating in a research note on Friday, September 5th. Seven analysts have rated the stock with a Buy rating and seventeen have assigned a Hold rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $289.50.

Humana Trading Down 2.9%

Shares of Humana stock opened at $254.35 on Friday. The stock has a market capitalization of $30.59 billion, a PE ratio of 19.52, a price-to-earnings-growth ratio of 1.54 and a beta of 0.44. Humana Inc. has a 52 week low of $206.87 and a 52 week high of $324.38. The stock has a 50 day moving average price of $271.22 and a two-hundred day moving average price of $257.28. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.95 and a current ratio of 1.95.

Humana (NYSE:HUM - Get Free Report) last issued its earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share for the quarter, missing analysts' consensus estimates of $6.32 by ($0.05). Humana had a return on equity of 13.67% and a net margin of 1.28%.The firm had revenue of $32.39 billion for the quarter, compared to analyst estimates of $31.85 billion. During the same period in the previous year, the company earned $6.96 earnings per share. Humana's revenue for the quarter was up 9.6% compared to the same quarter last year. Humana has set its FY 2025 guidance at 17.000- EPS. As a group, equities analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be given a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, September 26th. This represents a $3.54 annualized dividend and a dividend yield of 1.4%. Humana's payout ratio is presently 27.17%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.